TRACK(S): Management and Administration in OEM
Richard A. Feifer, MD, MPH, FACP, Aetna, Hartford, CT
Robert S. Goldsmith, MD, MPH*, Novartis Pharmaceuticals Corporation, East Hanover, NJ
Phillip J. Lerner, MD, MPH, FACOEM*, Aetna, Hartford, CT (Moderator)
Bruce W. Sherman, MD, FCCP, FACOEM*, Employers Health Coalition, Canton, OH
The pace of change in the way health care is provided and financed is accelerating. New solutions are being driven by medical inflation, a shortage of primary care providers, increasing prevalence of chronic illness, increase in health risks, advances in technology, and implementation of the Affordable Care Act (ACA). Benefits managers are no longer able to address cost and quality challenges through subtle changes of copays or services. Real benefits innovation is now essential. This session will highlight opportunities for corporate medical
directors to more strongly influence benefits strategy so that quality employee healthcare remains accessible and affordable, with an emphasis on the following: creating medical benefit plans that maintain access and affordability while mitigating or delaying the ACA excise tax; understanding and addressing the implication of employer migration to healthcare exchanges; and determining and optimizing the value of onsite care. This session is sponsored by the Corporate Medicine Special Interest Section.